https://insight.jci.org/articles/view/135982
https://www.ncbi.nlm.nih.gov/pubmed/32614803?dopt=Abstract
TITLE:
M3 muscarinic acetylcholine receptor reactive Th17 cells in primary Sjögren’s syndrome.
DESCRIPTION:
M3 muscarinic acetylcholine receptor reactive Th17 cells in primary Sjögren’s syndrome.
JCI Insight. 2020 Jul 02;:
Authors: Abe S, Tsuboi H, Kudo H, Asashima H, Ono Y, Honda F, Takahashi H, Yagishita M, Hagiwara S, Kondo Y, Matsumoto I, Sumida T
Abstract
M3 muscarinic acetylcholine receptor (M3R) is one of the autoantigens associated with Sjögren’s syndrome (SS) and is localized in exocrine glands where disease specific inflammation occurs. The inflammatory lesion is characterized by infiltration of CD4+ T cells, including clonally expanded Th17 cells. We undertook this study to identify circulating M3R specific Th17 cells, and to determine functional properties of those cells. Using ELISpot method, we identified M3R reactive Th17 cells in the peripheral blood of patients with primary SS (pSS). Among examined 10 pSS, 10 healthy subjects (HS), and 5 IgG4-related disease (IgG4-RD) patients, M3R reactive IL-17 secreting cells were significantly increased in five pSS patients specifically. The commonest T cell epitope, which was analyzed and confirmed by co-culture of isolated CD4+ T cells with antigen presenting cells plus M3R peptides in vitro, was peptide 83-95 of M3R. Peptide recognition was partly in HLA DR restricted manner, confirmed by blocking assay. M3R reactive Th17 cells positivity correlated with higher titers of anti-M3R antibodies, whose systemic disease activity score tended to be higher. Our studies highlight the role of tissue specific autoantigen derived circulating Th17 cells in pSS, for which further work might lead to antigen specific targeted therapy.
PMID: 32614803 [PubMed – as supplied by publisher]
PMID:
PubMed:32614803
DATE FOUND:
07/03/20 06:00AM
LINK / URL:
https://www.ncbi.nlm.nih.gov/pubmed/32614803?dopt=Abstract
